BOT 1.32% 37.5¢ botanix pharmaceuticals ltd

Ann: New Territory Licensed for Sofpironium Bromide with Kaken, page-16

  1. 4,390 Posts.
    lightbulb Created with Sketch. 1359
    BOT receives 25% of the royalty payments that Brickell receive I believe in the original agreement.

    This will start to add up in future years from Asian markets obviously.

    Good to see another diversified pipeline coming through.

    The real gold here is the FDA approval, which will automatically bring Europe in amongst other markets.

    BOT have indicated this is not material as compared to revenue from the USA it won't be, but obviously it is "unknown" at this stage.

    About time people grabbed a few under 10c imo.


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
-0.005(1.32%)
Mkt cap ! $669.7M
Open High Low Value Volume
37.0¢ 37.5¢ 36.0¢ $2.091M 5.672M

Buyers (Bids)

No. Vol. Price($)
8 70570 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 774578 11
View Market Depth
Last trade - 13.58pm 19/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.